Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,101,575 papers from all fields of science
Search
Sign In
Create Free Account
N 30
Known as:
N-30
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Guanidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Secondary Traumatization in Psychiatric Mental Health Nurses: Validation of Five Key Concepts
G. Hubbard
,
L. Beeber
,
Erin Eves
Perspectives in psychiatric care
2017
Corpus ID: 20875938
PURPOSE The purpose of this study was to validate five concepts central to secondary traumatization (ST) using narratives of…
Expand
2012
2012
Frequency Doubling Technology for Earlier Detection of Functional Damage in Standard Automated Perimetry-Normal Hemifield in Glaucoma With Low-to-Normal Pressure
Suguru Nakagawa
,
Hiroshi Murata
,
+5 authors
M. Araie
Journal of glaucoma
2012
Corpus ID: 7841556
PurposeTo compare the longitudinal change of frequency doubling technology (FDT) perimetry and standard automated perimetry (SAP…
Expand
2010
2010
In vivo expansion of MDR1‐transduced cells accompanied by a post‐transplantation chemotherapy regimen with mitomycin C and methotrexate
J. Mitsuhashi
,
Hiroyo Hosoyama
,
+7 authors
Y. Sugimoto
Journal of Gene Medicine
2010
Corpus ID: 32685061
A recurrent breast cancer patient received high‐dose chemotherapy, a transplant of multidrug resistance 1 (MDR1)‐transduced cells…
Expand
2010
2010
Potential of Stratus Optical Coherence Tomography for Detecting Early Glaucoma in Perimetrically Normal Eyes of Open-angle Glaucoma Patients With Unilateral Visual Field Loss
Yu Zhang
,
Lingling Wu
,
Yan-fang Yang
Journal of glaucoma
2010
Corpus ID: 38493631
PurposeTo evaluate the potential of stratus optical coherence tomography (OCT) for detecting early glaucoma. Patients and…
Expand
2006
2006
Visual field testing with the new Humphrey Matrix: a comparison between the FDT N-30 and Matrix N-30-F tests.
P. Brusini
,
M. L. Salvetat
,
M. Zeppieri
,
C. Tosoni
,
L. Parisi
,
M. Felletti
Acta ophthalmologica
2006
Corpus ID: 768833
PURPOSE To determine if the N-30-F test with the new Humphrey Matrix instrument is comparable to the traditional frequency…
Expand
2005
2005
Well log analysis at the White Rose oilfield, offshore Newfoundland
Jessica Jaramillo Sarasty
,
R. Stewart
2005
Corpus ID: 55927329
The petrophysical analysis in this paper is based on dipole sonic (Vp and Vs), density, gamma-ray, and porosity (density porosity…
Expand
2005
2005
Frequency Doubling Technology and Scanning Laser Tomography in Eyes With Generalized Enlargement of Optic Disc Cupping
S. Kunimatsu
,
G. Tomita
,
+7 authors
K. Yoshikawa
Journal of glaucoma
2005
Corpus ID: 21455583
Purpose:To characterize functional and structural changes in eyes with generalized enlargement of optic disc cupping (vertical…
Expand
2002
2002
Learning Effect and Measurement Variability in Frequency-Doubling Technology Perimetry in Chronic Open-Angle Glaucoma
H. Matsuo
,
G. Tomita
,
Yasuyuki Suzuki
,
M. Araie
Journal of glaucoma
2002
Corpus ID: 8474540
PurposeTo prospectively study the learning effects and measurement variability in frequency-doubling technology perimetry in…
Expand
1999
1999
Excitation of a Three-Dimensionally Localized Atomic Electron Wave Packet
J. Bromage
,
C. R. Stroud
1999
Corpus ID: 11563588
We have prepared an atomic electron in a three-dimensionally localized wave packet that travels along a highly eccentric orbit…
Expand
1987
1987
Immunosuppressive activity of 15-deoxyspergualin and its effect on skin allografts in rats.
T. Masuda
,
S. Mizutani
,
+5 authors
H. Umezawa
Journal of antibiotics (Tokyo. )
1987
Corpus ID: 13459061
The immunosuppressive activity of spergualin analogues, 15-deoxyspergualin and N-30, is presented. These compounds suppressed…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE